Cargando…

Industry influence in healthcare harms patients: myth or maxim?

Healthcare is a major global industry accounting for a significant proportion of government spending. Drug and medical device manufacturers are publicly traded companies with a responsibility to their shareholders to maximise profits by increasing sales. In order to achieve this, industry exerts inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Trayer, James, Rowbotham, Nicola J., Boyle, Robert J., Smyth, Alan R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584590/
https://www.ncbi.nlm.nih.gov/pubmed/36337122
http://dx.doi.org/10.1183/20734735.0010-2022
_version_ 1784813302138798080
author Trayer, James
Rowbotham, Nicola J.
Boyle, Robert J.
Smyth, Alan R.
author_facet Trayer, James
Rowbotham, Nicola J.
Boyle, Robert J.
Smyth, Alan R.
author_sort Trayer, James
collection PubMed
description Healthcare is a major global industry accounting for a significant proportion of government spending. Drug and medical device manufacturers are publicly traded companies with a responsibility to their shareholders to maximise profits by increasing sales. In order to achieve this, industry exerts influence over every part of healthcare including academic research, medical education, clinical guideline development, physician prescribing and through direct interactions with patients. In contrast, healthcare services seek to provide effective, safe and evidence-based treatments. This article examines interactions with industry across these domains and seeks to identify mutually beneficial relationships and potential conflict leading to patient harms. Case studies are used to illustrate these interactions. There is no single solution for improving healthcare's relationship with industry, although increased transparency has raised awareness of this issue. We briefly discuss some successful interventions that have been tried at national and regulatory level. While industry influence is widespread in healthcare and this has benefits for shareholders, healthcare practitioners have an ethical obligation to prioritise their patients’ best interests. Industry interactions with healthcare professionals have a valid role in product development and distribution, but industry sponsorship of healthcare education and practice, guideline development or regulatory decision-making can have harmful consequences for patients. Healthcare practitioners need to carefully consider these issues when deciding whether to collaborate with industry. EDUCATIONAL AIMS: To explore the many areas where industry influences healthcare and the subsequent effects on patient care. Case studies are used to illustrate examples of beneficial and harmful effects of this influence. To raise awareness of the effects of industry influence and for readers to consider their own potential conflicts of interest. To suggest potential ways to improve the current system with a focus on solutions which have successfully been trialled already.
format Online
Article
Text
id pubmed-9584590
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-95845902022-11-04 Industry influence in healthcare harms patients: myth or maxim? Trayer, James Rowbotham, Nicola J. Boyle, Robert J. Smyth, Alan R. Breathe (Sheff) Reviews Healthcare is a major global industry accounting for a significant proportion of government spending. Drug and medical device manufacturers are publicly traded companies with a responsibility to their shareholders to maximise profits by increasing sales. In order to achieve this, industry exerts influence over every part of healthcare including academic research, medical education, clinical guideline development, physician prescribing and through direct interactions with patients. In contrast, healthcare services seek to provide effective, safe and evidence-based treatments. This article examines interactions with industry across these domains and seeks to identify mutually beneficial relationships and potential conflict leading to patient harms. Case studies are used to illustrate these interactions. There is no single solution for improving healthcare's relationship with industry, although increased transparency has raised awareness of this issue. We briefly discuss some successful interventions that have been tried at national and regulatory level. While industry influence is widespread in healthcare and this has benefits for shareholders, healthcare practitioners have an ethical obligation to prioritise their patients’ best interests. Industry interactions with healthcare professionals have a valid role in product development and distribution, but industry sponsorship of healthcare education and practice, guideline development or regulatory decision-making can have harmful consequences for patients. Healthcare practitioners need to carefully consider these issues when deciding whether to collaborate with industry. EDUCATIONAL AIMS: To explore the many areas where industry influences healthcare and the subsequent effects on patient care. Case studies are used to illustrate examples of beneficial and harmful effects of this influence. To raise awareness of the effects of industry influence and for readers to consider their own potential conflicts of interest. To suggest potential ways to improve the current system with a focus on solutions which have successfully been trialled already. European Respiratory Society 2022-06 2022-07-12 /pmc/articles/PMC9584590/ /pubmed/36337122 http://dx.doi.org/10.1183/20734735.0010-2022 Text en Copyright ©ERS 2022 https://creativecommons.org/licenses/by-nc/4.0/Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
spellingShingle Reviews
Trayer, James
Rowbotham, Nicola J.
Boyle, Robert J.
Smyth, Alan R.
Industry influence in healthcare harms patients: myth or maxim?
title Industry influence in healthcare harms patients: myth or maxim?
title_full Industry influence in healthcare harms patients: myth or maxim?
title_fullStr Industry influence in healthcare harms patients: myth or maxim?
title_full_unstemmed Industry influence in healthcare harms patients: myth or maxim?
title_short Industry influence in healthcare harms patients: myth or maxim?
title_sort industry influence in healthcare harms patients: myth or maxim?
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584590/
https://www.ncbi.nlm.nih.gov/pubmed/36337122
http://dx.doi.org/10.1183/20734735.0010-2022
work_keys_str_mv AT trayerjames industryinfluenceinhealthcareharmspatientsmythormaxim
AT rowbothamnicolaj industryinfluenceinhealthcareharmspatientsmythormaxim
AT boylerobertj industryinfluenceinhealthcareharmspatientsmythormaxim
AT smythalanr industryinfluenceinhealthcareharmspatientsmythormaxim